================================================================================
BIOMARKER-SAMPLE PATH ANALYSIS
================================================================================

Summary:
- Paths to sepsis samples: 0
- Paths to healthy samples: 0

================================================================================
TOP INTERMEDIATE ENTITIES
================================================================================

These entities frequently appear between biomarkers and samples,
suggesting important mediating roles:


================================================================================
SAMPLE PATH STATISTICS
================================================================================

